BridgeMD
New treatment option for Stable Angina
Official title OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
ClinicalTrials.gov ID: NCT07198529
What this study is testing
What is Short DAPT?
Short DAPT is an investigational medicine, being studied as a potential treatment for stable angina.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate whether the use of optical coherence tomography (OCT), an advanced intravascular imaging tool, can improve stent implantation results and make it possible to shorten the duration of dual antiplatelet therapy (DAPT) in patients with stable angina who undergo percutaneous coronary intervention (PCI). PCI with drug-eluting stents is a standard treatment for patients with stable angina, and these patients are usually prescribed DAPT for 6 to 12 months to prevent stent thrombosis and other complications.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Patients who undergo PCI using a cobalt-chromium everolimus-eluting stent (CoCr-EES)
- Diagnosis of stable angina
- Ability and willingness to provide written informed consent approved by the Institutional Review Board (IRB), and to comply with the study protocol...
- Age ≥ 19 years
You likely can't join if
- Patients diagnosed with acute coronary syndrome (ACS), including unstable angina or acute myocardial infarction
- Contraindications to antiplatelet therapy or OCT imaging
- Presence of lesions with severe stenosis, heavy calcification, or marked vessel tortuosity that prevent passage of a guidewire or catheter
- Patients with previously implanted coronary stents in the target lesion
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Gurodong-ro, Guro-gu, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Gurodong-ro, Guro-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.